"25 años "Contigo en cada paso" Contamos con especialistas en cáncer y enfermedades de la sangre. Centro Medico Especializado en: Consulta Externa Interconsultas a pacientes hospitalizados Manejo integral del cancer y de las enfermedades de la sangre (Anemias) Aplicación de quimioterapia ambulatoria Cuidados paliativos y control crónico Manejo y cuidado de catèteres venosos centrales Factores de crecimiento hematopoyético Procedimiento de aspirado de médula òsea, biopsia de hueso Transfusión de sangre y sus derivados Apoyo a nuestros pacientes en el cuidado, orientación y sus tratamientos."

During the past decade, Centro Hemato Oncologico Panama conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Hemato Oncologico Panama" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Centro Hemato Oncologico Panama" are "Breast Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Cervical Cancer" (2 trials), "Adenocarcinoma" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Centro Hemato Oncologico Panama" in a lesser frequency.

Most popular intervention types in "Centro Hemato Oncologico Panama" are "Drug" (17 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (6 trials), "Paclitaxel" (6 trials), "Carboplatin" (5 trials), "Docetaxel" (5 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centro Hemato Oncologico Panama" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centro Hemato Oncologico Panama". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Centro Hemato Oncologico Panama, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Hemato Oncologico Panama, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".